Should I repeat the video esophagogastroduodenoscopy (V-EGD) for mild dysplasia in Barrett's esophagus?

Repeat EGD for Low-Grade Dysplasia in Barrett's Esophagus

Yes, you must repeat the EGD within 6 months after optimizing acid suppression with twice-daily PPI therapy for at least 2 months, performed by an expert endoscopist with resection of any visible lesions. 1

Initial Management Algorithm

When low-grade dysplasia (LGD) is first identified in Barrett's esophagus, the following steps are mandatory:

1. Optimize acid suppression: Start PPI twice daily, 30-45 minutes before meals for at least 2 months before repeat endoscopy 1

   • This is critical because uncontrolled reflux can cause regenerative changes that mimic dysplasia, leading to false-positive LGD diagnoses 1
   • Studies demonstrate that LGD may regress with effective reflux control 1

2. Expert pathology review: Have the initial biopsies reviewed by an expert GI pathologist 1

   • Expert pathology review upgrades LGD to high-grade dysplasia (HGD) in up to 26% of patients 1
   • Even more concerning, 7-11% are upgraded to esophageal adenocarcinoma (EAC), including some advanced cases 1

3. Repeat EGD by expert endoscopist: Schedule within 6 months while on maximum acid suppression 1

   • Must include resection of any visible lesions to rule out prevalent HGD or EAC 1
   • Use Seattle biopsy protocol: 4-quadrant biopsies every 1 cm 1

After Confirmation of LGD

Once LGD is confirmed on repeat endoscopy with expert review:

• Engage in shared decision-making regarding endoscopic eradication therapy (EET) versus continued surveillance 1
• If surveillance is chosen: EGD every 6 months for 1 year, then annually 1
  • Confirmed LGD progresses to HGD/EAC at 5.7% annually 1
  • If findings revert to non-dysplastic BE, can resume 3-year surveillance intervals 1

Key Risk Factors for Missed Dysplasia

Long-segment Barrett's esophagus (≥3 cm) is the most important predictor of missed dysplasia on initial endoscopy:

• Patients with long-segment BE have 3-fold higher odds of missed dysplasia 2
• In one study, 29.7% of long-segment BE cases had dysplasia detected on confirmatory endoscopy 3
• Short-segment BE (<3 cm) has much lower yield, with <1% dysplasia detection on repeat endoscopy 3

Additional risk factors include:

• Lack of PPI use at index endoscopy 4
• Multifocal or persistent LGD 5
• Presence of reflux esophagitis 5

Common Pitfalls to Avoid

1. Don't skip the PPI optimization step: Performing repeat endoscopy without adequate acid suppression leads to persistent inflammatory changes that confound dysplasia diagnosis

2. Don't accept community pathology alone: Expert GI pathology review is non-negotiable given the high upgrade rates

3. Don't assume short-segment BE is low-risk: While the yield is lower, dysplasia can still be missed

4. Don't delay repeat endoscopy beyond 6 months: The progression rate of confirmed LGD is 5.7% annually, making timely confirmation essential 1

The evidence strongly supports that dysplasia is commonly missed at initial BE diagnosis, with missed dysplasia rates of 9.5% overall 4 and even higher in long-segment disease. The repeat endoscopy protocol outlined above maximizes detection of prevalent neoplasia that would fundamentally change management from surveillance to treatment.